Article
Genetic variants in the circadian rhythm pathway as indicators of prostate cancer progression
5 Apr 2019
Abstract excerpt
To determine the association between circadian pathway genetic variants and the risk of prostate cancer progression. We systematically evaluated 79 germline variants in nine circadian pathway genes in a cohort of 458 patients with localized prostate cancer as the discovery phase. We then replicated the significant findings in another cohort of 324 men with more advanced disease. The association of each variant...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
